Comparison of bioavailability of curcuminoid-containing turmeric supplements after single oral administration in humans: a double-blind, four-way crossover study

Comparison of bioavailability of curcuminoid-containing turmeric supplements after single oral administration in humans: a double-blind, four-way crossover study - Comparison of oral bioavailability of turmeric supplements in humans

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016493

Enrollment

Registered

2015-02-10

Start date

2015-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Turmeric supplement 1 Single oral dose of the supplement containing about 30 mg of curcumin Turmeric supplement 2 Single oral dose of the supplement containing about 300 mg of curcumin Turmeric su

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Good general condition Body weight <= 80 kg 20<=BMI<25

Exclusion criteria

Exclusion criteria: Severe disease history Food or drug allergy Regular use or use within 2 weeks of turmeric-containing drugs or supplements

Design outcomes

Primary

Measure	Time frame
Plasma concentrations of curcuminoids and related pharmacokinetics parameters	—

Secondary

Measure	Time frame
Safety (biochemical examination of blood, medical examination by interview)	—

Countries

Japan

Contacts

Public ContactMakoto Terashima

Oneness Support Co., Ltd. Director

mterashima@oneness-sup.co.jp06-4801-8917

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026